BANK OF AMERICA CORP /DE/ - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$31,749
-61.9%
21,166
-74.7%
0.00%
Q4 2022$83,371
-60.9%
83,538
-29.6%
0.00%
Q3 2022$213,000
-46.8%
118,667
-14.0%
0.00%
Q2 2022$400,000
-32.9%
137,944
-36.1%
0.00%
Q1 2022$596,000
-89.6%
215,926
-82.4%
0.00%
-100.0%
Q4 2021$5,728,000
+593.5%
1,229,279
+1166.3%
0.00%
Q3 2021$826,000
+419.5%
97,073
+901.4%
0.00%
Q2 2021$159,000
-56.4%
9,694
-41.3%
0.00%
Q1 2021$365,000
+91.1%
16,505
+167.3%
0.00%
Q4 2020$191,000
+60.5%
6,175
+5.2%
0.00%
Q3 2020$119,000
+7.2%
5,871
-19.1%
0.00%
Q2 2020$111,000
+311.1%
7,253
+108.4%
0.00%
Q1 2020$27,000
-73.0%
3,480
-50.2%
0.00%
Q4 2019$100,000
+51.5%
6,990
+57.4%
0.00%
Q3 2019$66,000
+10.0%
4,440
+5.7%
0.00%
Q2 2019$60,000
+46.3%
4,202
+78.6%
0.00%
Q1 2019$41,0002,3530.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MPM BioImpact LLC 6,741,964$208,528,00018.01%
MPM ASSET MANAGEMENT LLC 4,050,865$125,293,00017.73%
Consonance Capital Management LP 584,885$71,268,0006.66%
SILVERARC CAPITAL MANAGEMENT, LLC 136,000$4,206,0002.44%
Redmile Group, LLC 2,832,888$87,621,0001.06%
Altium Capital Management LP 73,991$2,289,0000.86%
PFM Health Sciences, LP 775,794$23,995,0000.84%
Soleus Capital Management, L.P. 199,867$6,182,0000.82%
MOODY ALDRICH PARTNERS LLC 123,639$3,824,0000.62%
Sofinnova Investments, Inc. 333,707$10,322,0000.61%
View complete list of TCR2 THERAPEUTICS INC shareholders